Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie Schmaljohn

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Vaccine|October 20, 2009
Vaccines for hantavirusesConnie Schmaljohn
Virus Research|June 16, 2014
Foreword to the Virus Research special issue on "hantaviruses"Connie Schmaljohn, Alexander Plyusnin
Current Opinion in Virology|October 1, 2019
Editorial overview: Lassa virusConnie Schmaljohn, David Safronetz
Current Opinion in Virology|May 1, 2012
The interface of animal and human vaccinesConnie Schmaljohn, Christian W Mandl
Advances in Virus Research|January 13, 2004
DNA vaccines for flavivirusesRobert Putnak, Kevin Porter, Connie Schmaljohn
Advanced Drug Delivery Reviews|June 7, 2005
The role of particle-mediated DNA vaccines in biodefense preparednessHansi J Dean, Joel Haynes, Connie Schmaljohn
Methods (San Diego, Calif.)|September 26, 2006
Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseasesDeborah H Fuller, Peter Loudon, Connie Schmaljohn
Vaccine|March 2, 2010
Introduction to DNA vaccines - Las VegasDavid B Weiner, Niranjan Y Sardesai, Connie Schmaljohn
Current Opinion in Virology|September 1, 2019
A review of Lassa fever vaccine candidatesKolawole Salami, Dimitrios Gouglas, Connie Schmaljohn, et al.
Collegium Antropologicum|January 26, 2008
Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cellsAlemka Markotić, Lisa Hensley, Kathleen Daddario, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Vaccine|October 20, 2009
Vaccines for hantavirusesConnie Schmaljohn
Virus Research|June 16, 2014
Foreword to the Virus Research special issue on "hantaviruses"Connie Schmaljohn, Alexander Plyusnin
Current Opinion in Virology|October 1, 2019
Editorial overview: Lassa virusConnie Schmaljohn, David Safronetz
Current Opinion in Virology|May 1, 2012
The interface of animal and human vaccinesConnie Schmaljohn, Christian W Mandl
Advances in Virus Research|January 13, 2004
DNA vaccines for flavivirusesRobert Putnak, Kevin Porter, Connie Schmaljohn
Advanced Drug Delivery Reviews|June 7, 2005
The role of particle-mediated DNA vaccines in biodefense preparednessHansi J Dean, Joel Haynes, Connie Schmaljohn
Methods (San Diego, Calif.)|September 26, 2006
Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseasesDeborah H Fuller, Peter Loudon, Connie Schmaljohn
Vaccine|March 2, 2010
Introduction to DNA vaccines - Las VegasDavid B Weiner, Niranjan Y Sardesai, Connie Schmaljohn
Current Opinion in Virology|September 1, 2019
A review of Lassa fever vaccine candidatesKolawole Salami, Dimitrios Gouglas, Connie Schmaljohn, et al.
Collegium Antropologicum|January 26, 2008
Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cellsAlemka Markotić, Lisa Hensley, Kathleen Daddario, et al.
Pageof 5